E-LIB Suche - Ergebnisse für: Philippe Aftimos

1

Molecular imaging predicts lack of T-DM1 response in advanc..:

Mileva, Magdalena ; de Vries, Elisabeth G. E. ; Guiot, Thomas...
npj Breast Cancer. 10 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Correction: Krayem et al. Kinome Profiling to Predict Sensi..:

Krayem, Mohammad ; Aftimos, Philippe ; Najem, Ahmad...
Cancers. 16 (2024) 14 - p. 2587 , 2024

Link: https://doi.org/10.3390/..

3

EBCC-14 manifesto: Addressing disparities in access to inno..:

Ignatiadis, Michail ; Poulakaki, Fiorita ; Spanic, Tanja...
European Journal of Cancer. 207 (2024) - p. 114156 , 2024

Link: https://doi.org/10.1016/..

4

Elacestrant in ER+, HER2– MBC with ESR1-mutated tumors: Sub..:

Bardia, Aditya ; Cortes, Javier ; Bidard, Francois-Clement...
Clinical Cancer Research. , 2024

Link: https://doi.org/10.1158/..

5

Trastuzumab deruxtecan in patients with solid tumours harbo..:

Li, Bob T ; Meric-Bernstam, Funda ; Bardia, Aditya...
The Lancet Oncology. 25 (2024) 6 - p. 707-719 , 2024

Link: https://doi.org/10.1016/..

6

Modeling the novel SERD elacestrant in cultured fulvestrant..:

Dubash, Taronish D. ; Bardia, Aditya ; Chirn, Brian...
Breast Cancer Research and Treatment. 201 (2023) 1 - p. 43-56 , 2023

Link: https://doi.org/10.1007/..

7

Antibody–drug conjugates: the evolving field of targeted ch..:

Nader-Marta, Guilherme ; Molinelli, Chiara ; Debien, Véronique...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

8

Author Correction: Paclitaxel plus carboplatin and durvalum..:

Buisseret, Laurence ; Loirat, Delphine ; Aftimos, Philippe...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

9

Ki-67 index after neoadjuvant endocrine therapy as a progno..:

Martins-Branco, Diogo ; Nader-Marta, Guilherme ; Molinelli, Chiara...
European Journal of Cancer. 194 (2023) - p. 113358 , 2023

Link: https://doi.org/10.1016/..

10

Paclitaxel plus carboplatin and durvalumab with or without ..:

Buisseret, Laurence ; Loirat, Delphine ; Aftimos, Philippe...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

11

Trilaciclib Prior to Gemcitabine Plus Carboplatin for Metas..:

Goel, Shom ; Tan, Antoinette R ; Rugo, Hope S...
Future Oncology. 18 (2022) 33 - p. 3701-3711 , 2022

Link: https://doi.org/10.2217/..

12

PREDICT underestimates survival of patients with HER2-posit..:

Agostinetto, Elisa ; Ameye, Lieveke ; Martel, Samuel...
npj Breast Cancer. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

13

Delivering precision oncology to patients with cancer:

Mateo, Joaquin ; Steuten, Lotte ; Aftimos, Philippe...
Nature Medicine. 28 (2022) 4 - p. 658-665 , 2022

Link: https://doi.org/10.1038/..

14

First-in-man, first-in-class phase I study with the monopol..:

Schöffski, Patrick ; Awada, Ahmad ; de la Bigne, Anne-Marie...
European Journal of Cancer. 169 (2022) - p. 135-145 , 2022

Link: https://doi.org/10.1016/..

15

Post-Neoadjuvant Treatment Strategies for Patients with Ear..:

Agostinetto, Elisa ; Jacobs, Flavia ; Debien, Véronique...
Cancers. 14 (2022) 21 - p. 5467 , 2022

Link: https://doi.org/10.3390/..